Mateusz Zarzecki

Dr. Mateusz Zarzecki

Department of Ophthalmology, Medical University of Białystok, Bialystok, Poland
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
MOMichał Andrzej Okruszko
Michał Andrzej Okruszko
MSMaciej Szabłowski
Maciej Szabłowski
MZMateusz Zarzecki
Mateusz Zarzecki
MMMagdalena Michnowska-Kobylińska
Magdalena Michnowska-Kobylińska
ŁLŁukasz Lisowski
Łukasz Lisowski
Joanna KonopińskaJoanna Konopińska
Joanna Konopińska
Introduction: Glaucoma is the most common optic neuropathy and the leading cause of irreversible blindness worldwide, which affects 3.54% of the population aged 40– 80 years. Despite numerous published studies, some aspects of glaucoma pathogenesis, serum biomarkers, and their potential link with other diseases remain unclear. Recent articles have proposed that autoimmune, oxidative stress and inflammation may be involved in the pathogenesis of glaucoma. Methods: We investigated the serum expression of 92 inflammatory and neurotrophic factors in glaucoma patients. The study group consisted of 26 glaucoma patients and 192 healthy subjects based on digital fundography. Results: Patients with glaucoma had significantly lower serum expression of IL-2Rβ, TWEAK, CX3CL1, CD6, CD5, LAP TGF-beta1, LIF-R, TRAIL, NT-3, and CCL23 and significantly higher expression of IL-22Rα 1. Conclusion: Our results indicate that patients with glaucoma tend to have lower levels of neuroprotective proteins and higher levels of neuroinflammatory proteins, similar to those observed in psychiatric, neurodegenerative and autoimmune diseases, indicating a potential link between these conditions and glaucoma pathogenesis.

1 January 2024 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
MZMateusz Zarzecki
Mateusz Zarzecki
IOIwona Obuchowska
Iwona Obuchowska
AUAndrzej Ustymowicz
Andrzej Ustymowicz
Joanna KonopińskaJoanna Konopińska
Joanna Konopińska
Glaucoma is a common cause of blindness worldwide. This disease is characterised by increased intraocular pressure (IOP) and the concomitant disruption of ocular haemodynamic. Several studies have demonstrated that trabeculectomy is associated with changes in extraocular blood flow. In this study, we reviewed the available evidence on the use of colour Doppler imaging to evaluate and manage patients with open-angle glaucoma. We present the detailed anatomy of ocular blood flow to provide a background for the research findings. We also discuss the physiological foundations of ocular blood flow and detailed flow characteristics of specific extraocular vessels. Finally, we reviewed published studies that analysed the effects of glaucoma surgery on the blood flow parameters of the eye.

13 November 2025 in Cureus
Verified
Journal Article
Open access
PDF file
MZMateusz Zarzecki
Mateusz Zarzecki
IZIzabela Zawadzka
Izabela Zawadzka
BMBlanka Mitera
Blanka Mitera
MWMarzena Wojewódzka-Żelezniakowicz
Marzena Wojewódzka-Żelezniakowicz
JKJoanna Konopinska
Joanna Konopinska
Retinal artery occlusion (RAO) is an ophthalmic emergency primarily caused by systemic cardiovascular diseases. Central RAO (CRAO) may lead to severe visual loss, whereas branch retinal artery occlusion (BRAO) is associated with more benign symptoms and often resolves with less severe visual dysfunction. The etiopathogenesis of RAO is similar to that of ischemic stroke. It involves sudden occlusion of the retinal artery, leading to ischemia of the inner layers of the retina, retinal infarction, permanent damage to sensory cells, and resultant irreversible loss of vision. Although small-sample studies on the treatment of CRAO are available, only a few case series and reports on the efficacy of hyperbaric oxygen therapy (HBOT) in BRAO have been published. In this case series, we aimed to evaluate the effectiveness of HBOT in improving visual acuity in patients with BRAO based on an analysis of selected case reports. Patients underwent HBOT at 5, 36, and 48 hours after the onset of ocular symptoms, and visual acuity improved both quantitatively and qualitatively. HBOT has beneficial effects on the final visual acuity of patients following an episode of BRAO and may be a rescue treatment for early-stage BRAO, particularly when reperfusion is still feasible.

3 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MZMateusz Zarzecki
Mateusz Zarzecki
JBJakub Błażowski
Jakub Błażowski
IOIwona Obuchowska
Iwona Obuchowska
AUAndrzej Ustymowicz
Andrzej Ustymowicz
PKPaweł Kraśnicki
Paweł Kraśnicki
Joanna KonopińskaJoanna Konopińska
Joanna Konopińska
Background/Objectives: Glaucomatous neuropathy, a progressive deterioration of retinal ganglion cells, is the leading cause of irreversible blindness worldwide. While elevated intraocular pressure (IOP) is a well-established modifiable risk factor, increasing attention is being directed towards IOP-independent factors, such as vascular alterations. Color Doppler imaging (CDI) is a prominent technique for investigating blood flow parameters in extraocular vessels. This prospective, nonrandomized clinical trial aimed to assess the impact of ab externo canaloplasty on ocular blood flow parameters in patients with primary open-angle glaucoma (POAG) at a three-month follow-up. Methods: Twenty-five eyes of twenty-five patients with early or moderate POAG underwent canaloplasty with simultaneous cataract removal. CDI was used to measure peak systolic velocity (PSV), end-diastolic velocity (EDV), and resistive index (RI) in the ophthalmic artery (OA), central retinal artery (CRA), and short posterior ciliary arteries (SPCAs) before and after surgery. Results: The results showed a significant reduction in IOP and improvement in mean deviation at three months post-surgery. Best corrected visual acuity and retinal nerve fiber layer thickness significantly increased at each postoperative control visit. However, no significant changes were observed in PSV, EDV, and RI in the studied vessels. Conclusions: In conclusion, while canaloplasty effectively reduced IOP and medication burden, it did not significantly improve blood flow parameters in vessels supplying the optic nerve at three months post-surgery. Careful patient selection considering glaucoma severity and vascular risk factors is crucial when choosing between canaloplasty and more invasive procedures like trabeculectomy. Further larger studies are needed to comprehensively analyze this issue.